Last data update: May 06, 2024. (Total: 46732 publications since 2009)
Records 1-5 (of 5 Records) |
Query Trace: Houston KA[original query] |
---|
Lung cancer screening inconsistent with U.S. Preventive Services Task Force recommendations
Richards TB , Doria-Rose VP , Soman A , Klabunde CN , Caraballo RS , Gray SC , Houston KA , White MC . Am J Prev Med 2018 56 (1) 66-73 INTRODUCTION: Prior studies suggest overuse of nonrecommended lung cancer screening tests in U.S. community practice and underuse of recommended tests. METHODS: Data from the 2010 and 2015 National Health Interview Surveys was analyzed from 2016 to 2018. Prevalence, populations, and number of chest computed tomography (CT) and chest x-ray tests were estimated for people who did and did not meet U.S. Preventive Services Task Force (USPSTF) criteria for lung cancer screening, among people aged >/=40 years without lung cancer. RESULTS: In 2015, among those who met USPSTF criteria, 4.4% (95% CI=3.0%, 6.6%), or 360,000 (95% CI=240,000, 535,000) people reported lung cancer screening with a chest CT; and 8.5% (95% CI=6.5%, 11.1%), or 689,000 (95% CI=526,000, 898,000) people reported a chest x ray. Among those who did not meet USPSTF criteria, 2.3% (95% CI=2.0%, 2.6%), or 3,259,000 (95% CI=2,850,000, 3,724,000) people reported a chest x ray; and 1.3% (95% CI=1.1%, 1.5%), or 1,806,000 (95% CI=1,495,000, 2,173,000) people reported a chest CT. The estimated population meeting USPSTF criteria for lung cancer screening in 2015 was 8,098,000 (95% CI=7,533,000, 8,702,000), which was smaller than the 9,620,000 people (95% CI=8,960,000, 10,325,000) in 2010. CONCLUSIONS: The number of adults inappropriately screened for lung cancer greatly exceeds the number screened according to USPSTF recommendations, the prevalence of appropriate lung cancer screening is low, and the population meeting USPSTF criteria is shrinking. To realize the potential benefits of screening, better processes to appropriately triage eligible individuals to screening, plus screening with a USPSTF-recommended test, would be beneficial. |
Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county
Houston KA , Mitchell KA , King J , White A , Ryan BM . J Thorac Oncol 2018 13 (4) 497-509 INTRODUCTION: Lung cancer incidence is higher among NH blacks compared with NH white and Hispanic populations in the U.S. However, national cancer estimates may not always reflect the cancer burden in terms of disparities and incidence in small geographic areas, especially urban-rural disparities. Moreover, there is a gap in the literature regarding rural-urban disparities in terms of cancer histology. METHODS: Using population-based cancer registry data-Surveillance, Epidemiology and End Results (SEER) and National Program of Cancer Registries (NPCR)-we present age-adjusted histologic rates and trends by race/ethnicity, and residential county location at the time of first cancer diagnosis. Rate ratios were calculated to examine racial/ethnic differences in rates. Annual percent change (APC) was calculated to measure changes in rates over time. RESULTS: We find that declines in squamous cell carcinoma (SCC) are occurring fastest in metropolitan counties, while rates of adenocarcinoma increased fastest in counties non-adjacent to metropolitan areas. Further, while NH black men have increased lung cancer incidence compared with NH white and Hispanic men in all geographic locations, we find that the degree of the disparity increases with increasing rurality of residence. Finally, we report that among women diagnosed at less than 55 years of age, the incidence of SCC and adenocarcinoma was higher for NH blacks compared with NH whites. CONCLUSIONS: Our results highlight disparities among NH blacks in non-adjacent rural areas. These findings may have significant impact for the implementation of smoking cessation and lung cancer screening programs. |
Trends in prostate cancer incidence rates and prevalence of prostate-specific antigen screening by socioeconomic status and regions in the US, 2004- 2013
Houston KA , King J , Li J , Jemal A . J Urol 2017 199 (3) 676-682 BACKGROUND: It is unknown whether decreases in the prevalence of prostate-specific antigen (PSA) screening and prostate cancer incidence rates, following the US Preventive Service Task Force (USPSTF) recommendations against routine PSA, are similar across socioeconomic groups and US census regions. METHODS: We analyzed incidence rates and PSA screening prevalence by age, race/ethnicity, disease stage, US region, and area-level socioeconomic status. Annual percent changes were examined for changes in rates over time. Predicted marginal probability and 95% confidence intervals (CI) were calculated to estimate changes in PSA screening. RESULTS: Incidence rates for men age ≥50 years decreased in all race/ethnic, regional, and SES groups. From 2007-2013, overall incidence rates for localized cancers significantly decreased by 7.5% (95% CI; -10.5, -4.4) per year in age 50-74 years and by 11.1% (95% CI; -14.1, -8.1) per year in age ≥75 years. In contrast, incidence for distant-stage cancer significantly increased by 1.4% (95% CI; 0.3, 2.5) per year from 2008-2013 in age 50-74 years, but stabilized from 2011-2013 in age ≥75 years (5.1% per year, 95% CI; -3.4, 14.4). Distant-stage disease rates increased with increasing poverty-level in age 50-74, but not in age ≥75 years. CONCLUSIONS: Prostate cancer incidence decreased for early-stage disease in men 50 years and older, while rates for distant-stage disease slightly increased in men 50-74 years following USPSTF recommendations against routine PSA screening. Further studies with additional years of data are needed to substantiate our findings and monitor the effects of late stage disease increase on prostate cancer mortality rates. |
The essential role of public health in preventing disease, prolonging life, and promoting health of cancer survivors
Buchanan ND , Houston KA , Richardson LC . Am J Prev Med 2015 49 S467-9 Public health’s longstanding mission has been to “prevent disease, prolong life, and promote health” through organized efforts across societies, organizations, communities, and individuals.1 The public health community has worked to achieve this mission of combating both infectious and chronic disease through research and surveillance, public health programs, health communication activities, and policy and system changes. Cancer survivorship serves as an example of the dynamic work of the public health community in addressing this issue. | In the U.S., 14.5 million men, women, and children were estimated to be living after a cancer diagnosis (cancer survivors) in 2014.2 Cancer survivors routinely face physical, psychosocial, neurocognitive, spiritual, and financial challenges. The public health community has an essential role in addressing the needs of survivors and is uniquely positioned to intervene through prevention of recurrences, second cancers, and the side effects or consequences of cancer treatment to improve quality of life for each survivor. |
Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009
Houston KA , Henley SJ , Li J , White MC , Richards TB . Lung Cancer 2014 86 (1) 22-8 OBJECTIVE: The examination of lung cancer by histology type is important for monitoring population trends that have implications for etiology and prevention, screening and clinical diagnosis, prognosis and treatment. We provide a comprehensive description of recent histologic lung cancer incidence rates and trends in the USA using combined population-based registry data for the entire nation. MATERIALS AND METHODS: Histologic lung cancer incidence data was analyzed from CDC's National Program of Cancer Registries (NPCR) and the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program. Standardized rates and trends were calculated for men and women by age, race/ethnicity, and U.S. Census region. Rate ratios were examined for differences in rates between men and women, and annual percent change was calculated to quantify changes in incidence rates over time. RESULTS: Trend analysis demonstrate that overall rates have decreased, but incidence has remained stable for women aged 50 or older. Adenocarcinoma and squamous cell carcinoma were the two most common histologic subtypes. Adenocarcinoma rates continued to increase in men and women, and squamous cell rates increased in women only. All histologic subtype rates for white women exceeded rates for black women. Histologic rates for black men exceeded those for white men, except for small cell carcinoma. The incidence rate for Hispanics was nearly half the rate for blacks and whites. CONCLUSION: The continuing rise in incidence of lung adenocarcinoma, the rise of squamous cell cancer in women, and differences by age, race, ethnicity and region points to the need to better understand factors acting in addition to, or in synergy with, cigarette smoking that may be contributing to observed differences in lung cancer histology. |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure